This inventor holds 1 USPTO granted patent. Top assignee: Gilead Apollo, LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: John C Amedio, Jr: Innovator in ACC Inhibition
Introduction
John C Amedio, Jr. is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit Acetyl CoA Carboxylase (ACC). His work is crucial for advancing treatments for ACC-mediated diseases.
Latest Patents
Amedio holds a patent for "Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof." This invention provides solid forms of compounds that are useful as inhibitors of ACC, along with methods for their production and application in treating related diseases. He has 1 patent to his name.
Career Highlights
John C Amedio, Jr. is currently associated with Gilead Apollo, LLC, where he continues to innovate in the pharmaceutical sector. His expertise in ACC inhibition has positioned him as a valuable asset in the research and development of new therapeutic options.
Collaborations
Throughout his career, Amedio has collaborated with talented individuals such as Sijun Hu and Henry Morrison. These partnerships have enhanced the scope and impact of his research.
Conclusion
John C Amedio, Jr. exemplifies the spirit of innovation in the pharmaceutical industry, with his work on ACC inhibitors paving the way for new treatment possibilities. His contributions are vital for addressing ACC-mediated diseases and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile